New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
10:27 EDTDB, GE, LIFE, TMOLife Technologies surges after buyout report but analysts cautious
Life Technologies (LIFE) is climbing sharply after The Financial Post reported last night that the company is looking to sell itself by the middle of February for $65-$75 per share, according to unnamed sources. The company, which sells a variety of life sciences products, hired two firms, Deutsche Bank (DB) and Moelis & Co., to facilitate a sale of the company to either a private equity firm or a larger company, the newspaper added, citing documents. Life Technologies stated earlier today that it had hired Deutsche Bank and Moelis to "assist in its annual strategic review." The company added, however, that its board had not decided on any specific course of action. In a note to investors earlier today, Jefferies analyst Jon Wood wrote that Life Technologies is more likely to be acquired for $50-$60 per share in a leverage buyout. Wood maintained a $58 price target and Buy rating on the shares. Meanwhile, Piper analyst William Quirk wrote in a note to investors that the company may be planning a leveraged buyout. Several companies including Roche (RHHBY), Thermo Fisher (TMO), and GE (GE) could look to buy Life Technologies, Quirk added. However, about 43% of Life's revenues are obtained from selling slow growth research consumables, making it an inferior target compared with other companies in the sector that specialize in faster growing next-generation sequencing products, the analyst contended. He maintained a $45 price target and Neutral rating on the shares. Additionally, ISI Group said the company's high debt levels makes a leveraged buyout challenging and that a restructuring or recapitalization is the most likely outcome. In early trading, shares of Life Technologies rallied $6.42, or 11.68%, to $61.51.
News For LIFE;TMO;GE;DB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 16, 2014
14:57 EDTGEGeneral Electric says Alstom synergy opportunities better than expected
Subscribe for More Information
14:54 EDTGEGE repeats view for FY14 revenue flat to up 5%, consensus $148.92B
Subscribe for More Information
09:22 EDTGEGeneral Electric must answer on oil and gas focus after price slide, WSJ says
Subscribe for More Information
08:03 EDTGEGeneral Electric to acquire Oceaneering's Electric Actuator product line
Subscribe for More Information
05:56 EDTGEBoeing selects GE Aviation for ELMS on 777X
Subscribe for More Information
December 15, 2014
12:01 EDTGEBioTime unit, GE Healthcare sign set of license agreements, terms not disclosed
BioTime (BTX) announced that its subsidiary ES Cell International Pte. Ltd. and GE Healthcare (GE) have signed a set of license agreements through which GEHC received rights to ESI’s stem cell patents and ESI received rights to stem cell patents controlled by GEHC, in both cases for the development of cellular assays and models derived from stem cells for use in drug discovery and toxicity screening. In addition, the agreements give GEHC the right to grant sub-licenses to the ESI patent portfolio and, in certain circumstances, ESI may further sublicense its rights for the purpose of marketing stem cell-derived products. Financial terms were not disclosed.
11:17 EDTGEGE Aviation selected by Boeing for 777x common core avionics systems
Subscribe for More Information
08:15 EDTGEGeneral Electric to host investor meeting
Subscribe for More Information
08:08 EDTGEGeneral Electric enters into IP licensing agreement with WordLogic
Subscribe for More Information
December 12, 2014
11:57 EDTGEGeneral Electric increases dividend 5% to 23c from 22c
Subscribe for More Information
11:57 EDTGEGeneral Electric increases dividend 5% to 23c from 22c
Subscribe for More Information
December 11, 2014
13:40 EDTDBEuro zone banks accepted $160B in low interest loans, NY Times says
Subscribe for More Information
10:17 EDTDBFINRA fines Barclays Capital, Citigroup Global Markets, others $43.5M total
FINRA announced that it has fined 10 firms a total of $43.5M for allowing their equity research analysts to solicit investment banking business and for offering favorable research coverage in connection with the 2010 planned initial public offering of Toys"R"Us. FINRA fined the following firms. Barclays Capital (BCS) - $5M; Citigroup Global Markets (C) – $ 5M; Credit Suisse Securities (CS) – $5M; Goldman, Sachs & Co. (CS) – $5M; JP Morgan Securities LLC (JPM) – $5M; Deutsche Bank Securities Inc. (DB) – $4M; Merrill Lynch, Pierce, Fenner & Smith Inc. (BAC) – $4M; Morgan Stanley & Co., LLC (MS) – $4M; Wells Fargo Securities, LLC (WFC) – $4M; Needham & Company LLC – $2.5M. In addition, FINRA found that six of the 10 firms — Barclays, Citigroup, Credit Suisse, Goldman Sachs, JP Morgan and Needham — had inadequate supervisory procedures related to research analyst participation in investment banking pitches. Toys"R"Us and its sponsors offered each of the 10 firms various roles in the IPO but it eventually decided not to proceed with the offering. In settling this matter, the 10 firms neither admitted nor denied the charges, but consented to the entry of FINRA's findings.
06:40 EDTDBNY investigating Deutsche Bank, Barclays currency trading, Reuters reports
Subscribe for More Information
December 10, 2014
08:04 EDTGEGE Energy Financial Services, Pacifico to build second joint solar project
Subscribe for More Information
December 8, 2014
15:26 EDTDBDeutsche Bank sued by U.S. over alleged scheme to avoid income taxes
Subscribe for More Information
15:10 EDTDBDOJ files suit against Deutsche Bank over income tax avoidance, Bloomberg says
Subscribe for More Information
10:00 EDTDBOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:40 EDTDBDeutsche Bank and Cisco to host a conference call
Subscribe for More Information
06:00 EDTDBDeutsche Bank downgraded to Underperform from Market Perform at Keefe Bruyette
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use